Detalles de la búsqueda
1.
CASCADE: a phase 2, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the effect of tezepelumab on airway inflammation in patients with uncontrolled asthma.
Respir Res
; 21(1): 265, 2020 Oct 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33050900
2.
Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR.
J Asthma Allergy
; 16: 915-932, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37692126
3.
Tezepelumab and Mucus Plugs in Patients with Moderate-to-Severe Asthma.
NEJM Evid
; 2(10): EVIDoa2300135, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-38320181
4.
Tezepelumab Pharmacokinetics, Safety, and Tolerability After Administration via Vial-and-syringe, Accessorized Prefilled Syringe, or Autoinjector: A Randomized Trial in Healthy Volunteers.
Clin Ther
; 43(1): 142-155.e5, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33380362
5.
Functionality and Performance of an Accessorized Pre-Filled Syringe and an Autoinjector for At-Home Administration of Tezepelumab in Patients with Severe, Uncontrolled Asthma.
J Asthma Allergy
; 14: 381-392, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33907423
6.
Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial.
Lancet Respir Med
; 9(11): 1299-1312, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34256031
7.
Evaluation of Antibody Properties and Clinically Relevant Immunogenicity, Anaphylaxis, and Hypersensitivity Reactions in Two Phase III Trials of Tralokinumab in Severe, Uncontrolled Asthma.
Drug Saf
; 42(6): 769-784, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30649752
Resultados
1 -
7
de 7
1
Próxima >
>>